A new study has revealed an impressive weight-loss drug that reduces caloric intake by more than a third, suppresses appetite, and decreases food cravings. Patients who received a weekly injection lost 10% of their body weight in just 20 weeks, which is 25 times faster than those who took a placebo. Those who received the drug reported feeling less hungry, felt full faster, and consumed 35% fewer calories. Experts say the drug, called semaglutide, could play a key role in combating the obesity crisis and is already used to treat type 2 diabetes by hijacking the body's appetite regulation system.
Researchers from the British pharmaceutical company Novo Nordisk analyzed data from 72 adults aged 18 to 65 suffering from obesity. Half were given an injection while the other half received a placebo. Participants completed surveys regarding their eating habits and appetite at the beginning of the trial and again after 20 weeks. Patients who received the drug consumed 1,736 calories, which is 940 calories fewer than those who received the placebo. Those who received the vaccine lost an average of 9.9% of their body weight, compared to 0.4% for those on the placebo, according to the Daily Mail.
